Barinthus Biotherapeutics plc. — Investor Relations & Filings
Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company that develops novel immunotherapies designed to guide T cells to control disease. The company is advancing a new generation of antigen-specific immunotherapeutics for treating autoimmunity, chronic infectious diseases, and cancer. Its therapeutic approach focuses on creating candidates that can overcome these conditions by modulating the body's T cell response. The development pipeline includes programs targeting various indications, with a strategic focus on immunology and inflammatory diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-21 | English | |
| 10-Q - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-04-30 | English | |
| 8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-04-30 | English | |
| 8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-04-22 | English | |
| 8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-02-23 | English | |
| 8-K | 2026-01-06 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 46726643 | FORM 8-K | 2026-05-21 | English | ||
| 39074800 | 10-Q - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-04-30 | English | ||
| 39072782 | 8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-04-30 | English | ||
| 35399458 | 8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-04-22 | English | ||
| 32826299 | 8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer) | 2026-02-23 | English | ||
| 13323828 | 8-K | 2026-01-06 | English | ||
|
2025
9 filings
| |||||
| 13323834 | 8-K | 2025-12-10 | English | ||
| 13323802 | 10-Q | 2025-11-07 | English | ||
| 13323835 | 8-K | 2025-11-07 | English | ||
| 13323803 | FORM 8-K | 2025-09-30 | English | ||
| 31941198 | 425 Filing | 2025-09-30 | English | ||
| 31941195 | 425 Filing | 2025-09-30 | English | ||
| 13323832 | FORM 8-K/A | 2025-08-08 | English | ||
| 13323804 | 10-Q | 2025-08-07 | English | ||
| 13323808 | 8-K | 2025-08-07 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Barinthus Biotherapeutics plc., but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abbott Laboratories (Pakistan) Limited
Manufactures and markets diverse healthcare products: pharm…
|
ABOT | PK | Manufacturing |
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
Barinthus Biotherapeutics plc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34488/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34488 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34488 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34488 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34488}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Barinthus Biotherapeutics plc. (id: 34488)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.